WealthStone’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$360K Buy
1,003
+60
+6% +$19.3K 0.13% 124
2020
Q4
$303K Buy
943
+96
+11% +$29.5K 0.11% 130
2020
Q3
$227K Buy
+847
New +$228K 0.1% 144
2019
Q3
Sell
-397
Closed -$112K 226
2019
Q2
$112K Buy
+397
New +$108K 0.05% 135

Other funds holding ELV

WealthStone's ELV Position: Q1 2021 in Review

WealthStone increased its Elevance Health (ELV) stake by 6.4% in Q1 2021, buying an estimated $19.3K and bringing the position to 1,003 shares worth $360K. The position accounts for 0.13% of the portfolio, ranked #124.

WealthStone first reported a position in ELV in Q2 2019 and has held it in 4 quarters since. 1,211 funds tracked by Wall St. Rank hold ELV as of Q1 2021.

  • WealthStone held 1,003 shares of Elevance Health worth $360K as of Q1 2021.
  • WealthStone bought 60 Elevance Health shares in Q1 2021, an estimated $19.3K.
  • Elevance Health made up 0.13% of WealthStone's portfolio in Q1 2021, its #124 holding.
  • WealthStone first reported a position in Elevance Health in Q2 2019 and has held it in 4 quarters since.
  • 1,211 funds tracked by Wall St. Rank held Elevance Health as of Q1 2021.

Based on WealthStone's 13F filing for Q1 2021, filed 13 May 2021.